IP Library Granted Patent US 10,729,589
Granted Patent B2
US 10,729,589 · App. 15/431,589 · Granted Aug 4, 2020

Compressive oxygen diffusive wound dressings

Inventors: Randy Dorian (San Diego, CA); Richard W. Storrs (Berkeley, CA); Michael D. Leach (Warsaw, IN); Alexander B. Izvorski (San Francisco, CA)
Assignee: Hanuman Pelican, Inc.
A61F13/00068A61F13/00029A61F13/00063A61F13/022A61F13/025A61M35/30A61M37/00A61F2013/0028A61F2013/00246
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,729,589
App. No.
15/431,589
Granted
Aug 4, 2020
Kind
B2
Abstract

Oxygen diffusive wound dressings and methods of manufacturing and use are described herein. The wound dressing may generally provide a ready supply of oxygen to a wound being treated via one or more oxygen conduits which are designed to pass oxygen from ambient air or other oxygen reservoirs into proximity to the wound, and may also provide for exudate removal through transecting channels in fluid communication with both the wound surface and a hydrophilic absorbent material.

Claims (14)

1. A method of treating a wound, comprising:

providing a wound dressing having a compressible pad which defines at least one protrusion and further having an oxygen-diffusive substrate which is water resistant and defines a contact surface and a hydrophilic absorbent material in fluid communication with at least one portion of a periphery of the oxygen-diffusive substrate;

pressing at least a portion of the substrate against the wound such that the at least one protrusion contacts and conforms the substrate to a surface of the wound and exudate from the wound is urged to flow laterally along the substrate and into the absorbent material; and,

diffusing oxygen through the oxygen-diffusive substrate and into the wound.

2. The method of claim 1 wherein the oxygen-diffusive substrate is comprised of silicone.

3. The method of claim 1 further removing excess exudate from the wound via at least one access port upon the wound dressing.

4. The method of claim 1 further comprising infusing a drug, medicant or agent into the wound dressing.

5. The method of claim 1 wherein pressing at least a portion of the substrate against the wound comprises pressing against the wound via the at least one protrusion.

6. The method of claim 1 wherein pressing at least a portion comprises adhering the wound dressing around a periphery of the wound via an adhesive border.

7. The method of claim 1 further comprising wicking the exudate across the substrate via one or more channels or grooves defined along the contact surface.

8. The method of claim 7 wherein the channels or grooves transect the contact surface.

9. The method of claim 1 wherein pressing at least a portion of the substrate against the wound comprises introducing a fluid or gas via a reservoir fluidly coupled to the substrate.

10. The method of claim 9 further comprising cycling the fluid or gas through the wound dressing via one or more ports.

11. The method of claim 1 further comprising removing and/or replacing the absorbent material without removing the oxygen-diffusive substrate from the wound.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME IS --ANUBIS MEDICAL, LLC PREVIOUSLY RECORDED AT REEL: 41697 FRAME: 793. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 9, 2024
From: ANUBIS MEDICAL, LLC
To: OWL MANOR, LLC
Reel/Frame 066545/0447 →
CHANGE OF NAME Recorded Feb 9, 2024
From: OWL MANOR, LLC
To: OWL MANOR MEDICAL, LLC
Reel/Frame 067533/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2017
From: DORIAN, RANDY; STORRS, RICHARD W.; LEACH, MICHAEL D.; IZVORSKI, ALEXANDER B.
To: ANUBIS MEDICAL, LLC
Reel/Frame 041243/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2017
From: OWL MANOR MEDICAL, LLC
To: HANUMAN PELICAN, INC.
Reel/Frame 041243/0463 →
CHANGE OF NAME Recorded Feb 13, 2017
From: ANUBIS LLC
To: OWL MANOR, LLC
Reel/Frame 041697/0793 →
Continuity (3)
Division 13692343 · Dec 3, 2012
Continuation In Part 13650003 · Oct 11, 2012
Related Publication 20170165117A1 · Jun 15, 2017
Cited By (6)
US 1,094,725 US 1,095,846 US 1,147,392 US 1,147,393 US 12,290,655 US 12,458,540